NCT07367022 Portable Sleep Monitors in Children With Autism Spectrum Disorder
| NCT ID | NCT07367022 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lena Xiao |
| Condition | Autism Spectrum Disorder (ASD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-08-12 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2025-08-12 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate the ability of a portable sleep monitor to detect obstructive sleep apnea in children with autism spectrum disorder (ASD). The main study objectives are to: 1. Evaluate the correlation between the obstructive apnea-hypopnea index (OAHI) on a portable sleep monitor and an in-laboratory polysomnogram (PSG); 2. Determine the sensitivity and specificity of a portable sleep monitor to diagnose obstructive sleep apnea (OSA); 3. Evaluate patient and family preferences for sleep testing.
Eligibility Criteria
Inclusion Criteria: 1. Children between 6 to 18 years of age, AND; 2. Children diagnosed with autism spectrum disorder, AND; 3. Children who will be undergoing a polysomnogram (PSG) for the first time, AND; 4. Caregiver willing to complete questionnaires about child's sleep and behavior Exclusion Criteria: 1. Children who are currently using respiratory therapy 2. Children who have previously completed a PSG 3. Caregiver unwilling to complete questionnaires about child's sleep and behavior
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07367022 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying Autism Spectrum Disorder (ASD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07367022 currently recruiting?
Yes, NCT07367022 is actively recruiting participants. Contact the research team at lena.xiao@cw.bc.ca for enrollment information.
Where is the NCT07367022 trial being conducted?
This trial is being conducted at Vancouver, Canada.
Who is sponsoring the NCT07367022 clinical trial?
NCT07367022 is sponsored by Lena Xiao. The trial plans to enroll 20 participants.